ECO Q1 2026 Earnings EPS Beats Estimates by a Wide Margin Stock Dips Despite Strong Performance Cartesian Therapeutics Inc RNAC Q1 2026 Earnings ClinicalStage Biotech Reports WiderThanExpected Loss Stock Ticks Higher EPSN Q1 2026 Earnings Positive EPS Amid Modest Market Reaction Upstream Bio Q1 2026 Earnings NarrowerthanExpected Loss Amid Clinical Progress Immunome Inc IMNM Q1 2026 Earnings Narrower Loss Beats Estimates Stock Gains Modestly Lufax Holding Q3 2024 Earnings Staggering EPS Miss Sends Shares Lower